HBM Healthcare Investments Aktie 1262725 / CH0012627250
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
05.01.2026 17:47:13
|
Key Figures 31.12.2025
|
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
HBM Healthcare Investments AG
Bundesplatz 1
CH-6300 Zug - Switzerland
Tel. +41 41 710 75 77
Wenn Sie keine Mitteilungen von HBM Healthcare Investments mehr wünschen, können Sie diese hier abbestellen.
Should you wish to unsubscribe from all HBM Healthcare Investments news, please unsubscribe here.
Disclaimer:
This message may contain confidential or privileged Information and is intended only for the use of the addressee named above. If you are not the intended recipient of this message, you are hereby notified that you must not use, copy, disclose or take any action based on this message or information herein. If you have received this message by error, please advise the sender immediately and delete this message. This document constitutes marketing material and is intended to be for information purposes only and should not be construed as an offer or recommendation for transactions. The information does not take into account any personal circumstances and does not qualify as general or personal investment recommendation or advice. Statements regarding the past performance may not be understood as indication for the current or future performance. The value of investments and the income therefrom may fluctuate. A good past performance may possibly not be repeated in the future. It is possible that the investor will not be paid back the full amount invested. Performance data does not take into account any commissions and costs charged when units of the Fund are issued and redeemed. An investment entails risks, which are fully described in the individual offering documents. Some information quoted was obtained from external sources HBM considers to be reliable. HBM cannot guarantee the adequacy, accuracy, timeliness or completeness of or be held responsible or liable for errors of fact regarding such data and information obtained from third parties, and this data may change with market conditions. 08/2025 If the email looks unformatted, please use this alternative link.
End of Media Release |
|||||||||||||||||||||||||
| Language: | English |
| Company: | HBM Healthcare Investments AG |
| Bundesplatz 1 | |
| 6300 Zug | |
| Switzerland | |
| Phone: | +41438887171 |
| Fax: | +41438887172 |
| E-mail: | info@hbmhealthcare.com |
| Internet: | https://www.hbmhealthcare.com |
| ISIN: | CH0012627250 |
| Valor: | 1262725 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2254914 |
| End of News | EQS News Service |
|
|
2254914 05.01.2026 CET/CEST
Nachrichten zu HBM Healthcare Investments AG
|
05.01.26 |
HBM Healthcare Investments once again delivered strong value growth in the 2025 calendar year despite currency headwind (EQS Group) | |
|
05.01.26 |
HBM Healthcare Investments erzielte trotz negativer Währungseinflüsse im Kalenderjahr 2025 erneut eine hohe Wertsteigerung (EQS Group) | |
|
05.01.26 |
Key Figures 31.12.2025 (EQS Group) | |
|
16.12.25 |
Key Figures 15.12.2025 (EQS Group) | |
|
15.12.25 |
HBM-Aktie steigt: Swixx-Beteiligung wird zum Grossteil abgestossen (AWP) | |
|
15.12.25 |
HBM Healthcare Investments gibt Vereinbarung zum Verkauf einer Mehrheitsbeteiligung an Swixx Biopharma bekannt (EQS Group) | |
|
15.12.25 |
HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma (EQS Group) | |
|
08.12.25 |
Mirum Pharmaceuticals übernimmt HBM Portfoliounternehmen Bluejay Therapeutics für bis zu USD 820 Millionen (EQS Group) |
Analysen zu HBM Healthcare Investments AG
3 neue Aktien 📈 BX Musterportfolio: Lam Research, Safran SA & HSBC Holdings mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt – heute mit dem monatlichen Rebalancing:
NEU✅ Lam Research
NEU✅ Safran SA
NEU✅ HSBC Holdings
inklusive Rebalancing:
❌ Quanta Services Inc
❌ AENA
❌ Trane Technologies
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
HBM Healthcare Investments am 05.01.2026
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI fällt nach Rekordhoch an Nulllinie zurück -- DAX knackt 25'000er-Marke -- Zurückhaltung an US-Börsen erwartet -- Asiens Börsen letztlich mehrheitlich im MinusDer heimische Aktienmarkt tritt am Mittwoch auf der Stelle, während der deutsche Leitindex zulegt. In den USA stehen die Zeichen zumindest vorerst eher auf Konsolidierung. Die Märkte in Fernost wiesen überwiegend rote Vorzeichen aus.


